{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":286,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":286,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"2f253091c182","filters":{"venue":"Current Medical Research and Opinion"}},"results":[{"id":"W1999059326","doi":"10.1185/030079904125003467","title":"The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence oSf erectile dysfunction and related health concerns in the general population","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Bayer Corporation","keywords":"Medicine; Erectile dysfunction; Demography; Dyslipidemia; Depression (economics); Population; Gerontology; Prevalence; Disease; Psychiatry; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1586686421148424,"gpt":0.5006145562333871,"spread":0.3419459141185447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004180756,0.000107266,0.0001765772,0.00011876,0.0006791202,0.00004699654,0.00006700814,0.00005935093,0.00005081923],"category_scores_gemma":[0.00343931,0.00006205875,0.00001458656,0.0003425323,0.0001980279,0.00008499605,0.0001249163,0.0005268915,0.00001030129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001273851,"about_ca_system_score_gemma":0.0002111797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005775951,"about_ca_topic_score_gemma":0.0002153584,"domain_scores_codex":[0.9971631,0.0005511926,0.0003368376,0.0003665411,0.001302362,0.000279964],"domain_scores_gemma":[0.9986203,0.0006267722,0.00005253071,0.0001461105,0.0001680385,0.0003862643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006626672,0.0009110803,0.8518222,0.000298242,0.00004752651,0.000002697813,0.003015352,0.000007096929,0.000005848752,0.002485364,0.005126186,0.1356157],"study_design_scores_gemma":[0.002593941,0.001028553,0.9848155,0.0002009905,0.000005233388,0.00001614664,0.002265017,0.0002498113,5.974855e-7,0.0003686949,0.008397565,0.00005792543],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9672284,0.003986724,0.0001154647,0.02654834,0.0006948426,0.001296704,0.000005673058,0.00002359739,0.0001002881],"genre_scores_gemma":[0.9936273,0.005293394,0.00001103025,0.0003047011,0.0003359345,0.0001259547,0.00003868813,0.000006061025,0.0002569578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1355578,"threshold_uncertainty_score":0.5223312,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099652899","doi":"10.1185/030079904x2051","title":"Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"AstraZeneca","keywords":"Budesonide; Formoterol; Medicine; Budesonide/formoterol; Inhaler; Exacerbation; Asthma; Corticosteroid; Anesthesia; Terbutaline; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1060257200970963,"gpt":0.415323229223966,"spread":0.3092975091268698,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006874801,0.0001452486,0.0003698759,0.0002651591,0.00006257847,0.00001358049,0.0001108821,0.0001322244,0.0001256456],"category_scores_gemma":[0.0007023032,0.0001039729,0.00004698814,0.0003584388,0.0004062759,0.00007439757,0.0001334325,0.0004270816,0.000005710829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000783284,"about_ca_system_score_gemma":0.0004514645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006123433,"about_ca_topic_score_gemma":0.00002646856,"domain_scores_codex":[0.9976873,0.0001234416,0.0003915949,0.0003126949,0.001085623,0.0003993861],"domain_scores_gemma":[0.9985172,0.00029332,0.00004899804,0.0002009319,0.0001746588,0.0007649287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02791635,0.002349792,0.005438629,0.0006558815,0.00004497505,0.00004597182,0.0007465529,0.00001947343,0.001781151,0.0005472985,0.0002486511,0.9602053],"study_design_scores_gemma":[0.1132501,0.02426131,0.721518,0.01281451,0.00002136789,0.00004615583,0.0005944999,0.0004183183,0.005039925,0.000786323,0.1206097,0.0006397701],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903795,0.006994413,0.00008542599,0.001478752,0.00021123,0.0006277316,0.00001404757,0.00001153511,0.0001973508],"genre_scores_gemma":[0.995006,0.004608057,0.0000665589,0.00006483361,0.000176866,0.00002004312,0.00002002888,0.00001444984,0.000023127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9595655,"threshold_uncertainty_score":0.4239891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140719894","doi":"10.1185/030079905x56565","title":"Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Rivastigmine; Donepezil; Tolerability; Medicine; Adverse effect; Discontinuation; Cholinesterase; Internal medicine; Dementia; Population; Randomized controlled trial; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.1425517985465833,"gpt":0.4508608017460685,"spread":0.3083090031994851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002738963,0.0001907125,0.0002873162,0.000242941,0.000129041,0.00006717882,0.00006258181,0.00006105639,0.0001962139],"category_scores_gemma":[0.0005004545,0.0001395141,0.00004371804,0.0002235778,0.0001676995,0.0001222912,0.000126047,0.0003095409,0.00002627278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006920335,"about_ca_system_score_gemma":0.0004075764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002678854,"about_ca_topic_score_gemma":0.00004532679,"domain_scores_codex":[0.9978377,0.0001385325,0.0002421039,0.0005166452,0.0008153622,0.0004496883],"domain_scores_gemma":[0.9975959,0.0001368023,0.00001593482,0.0002051881,0.0001098054,0.001936362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0175627,0.005209558,0.07553997,0.000438013,0.0001247903,0.000540741,0.002025407,0.00006977791,0.0004476391,0.0009699221,0.01039387,0.8866776],"study_design_scores_gemma":[0.04068325,0.00548048,0.6654848,0.004591804,0.0001730076,0.0001732283,0.0004656701,0.1154567,0.002571805,0.0008781577,0.1627309,0.001310069],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9714081,0.01838705,0.00004283954,0.009253505,0.00009534744,0.0006821618,0.00005154479,0.00001904075,0.00006042548],"genre_scores_gemma":[0.9878314,0.01073438,0.00003948923,0.0003225451,0.0007043977,0.0001460941,0.0001220643,0.00001788517,0.00008179455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8853676,"threshold_uncertainty_score":0.5689219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146626244","doi":"10.1185/030079906x158066","title":"Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Mount Sinai Hospital; PharmIdeas (Canada)","funders":"Bayer Canada; Bayer HealthCare","keywords":"Medicine; Neuropathic pain; Multiple sclerosis; Cannabis; Meta-analysis; Cannabidiol; Psychiatry; Internal medicine; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.4307523687674539,"gpt":0.485612677205926,"spread":0.05486030843847217,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009062513,0.0004484444,0.003838918,0.001726266,0.0002093069,0.00005856013,0.0002572516,0.0005142405,0.0002864191],"category_scores_gemma":[0.005729048,0.0002841214,0.001857463,0.001989744,0.0008232978,0.00003869125,0.000193422,0.001280812,0.000002831579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001438571,"about_ca_system_score_gemma":0.001725402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003393157,"about_ca_topic_score_gemma":0.0000529596,"domain_scores_codex":[0.9927104,0.001924356,0.001110515,0.0009412649,0.002493761,0.0008197608],"domain_scores_gemma":[0.9960821,0.001281298,0.0002387561,0.0005586177,0.0006695977,0.001169618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009079986,0.00066969,0.00008236884,0.02111426,0.0226478,0.00001159803,0.00001653546,3.704848e-7,9.185996e-7,0.00004381267,0.02636383,0.928958],"study_design_scores_gemma":[0.001422986,0.001161879,0.0002463582,0.003119698,0.07037508,0.00000589023,0.000007757699,0.004155057,0.000001941183,0.00002184708,0.9192761,0.0002053966],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005413349,0.9942914,0.0001772518,0.001973639,0.0001365777,0.002676847,0.0006440169,0.00001991907,0.00002625362],"genre_scores_gemma":[0.0001768653,0.9950984,0.00002220303,0.00002679334,0.0001411422,0.0008958715,0.002389536,0.00005616838,0.001193006],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9287526,"threshold_uncertainty_score":0.9999611,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2960566636","doi":"10.1080/03007995.2019.1636017","title":"Bipolar depression: the clinical characteristics and unmet needs of a complex disorder","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Bipolar disorder; Medicine; Psychiatry; Depression (economics); Mania; Hypomania; Anxiety; Comorbidity; Prevalence of mental disorders; Psychosocial; Substance abuse; Mood","retraction":null,"screen_n_in":null,"score":{"opus":0.3659037293290053,"gpt":0.5502939973862744,"spread":0.1843902680572691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002202388,0.0002767442,0.0015582,0.000252666,0.0001459571,0.00003049691,0.0002496088,0.0004154375,0.0002136614],"category_scores_gemma":[0.001512859,0.0001386592,0.0002505648,0.0004085141,0.001016353,0.00002773738,0.0005228532,0.001860808,0.00003509595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002678379,"about_ca_system_score_gemma":0.0008010648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002389169,"about_ca_topic_score_gemma":0.000004528129,"domain_scores_codex":[0.9964013,0.0007322226,0.0008183037,0.0003641636,0.001266026,0.0004180282],"domain_scores_gemma":[0.9966251,0.001868789,0.000175953,0.0005178608,0.0001629151,0.0006493469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000465862,0.0005246864,0.01900531,0.01753588,0.0001553194,0.000001846271,0.00004570439,1.95129e-10,2.336801e-8,0.0002455492,0.001416822,0.9610223],"study_design_scores_gemma":[0.0009951114,0.0006010451,0.01426424,0.01483177,0.0002616932,0.0000604017,0.00003789344,0.00002521359,3.385916e-8,0.00003923674,0.9687681,0.0001152138],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008437283,0.9973007,0.00004439598,0.0005004356,0.0005613226,0.001284028,0.0001011054,0.00001115507,0.0001125291],"genre_scores_gemma":[0.0004872811,0.9981191,0.00001214113,0.00001557753,0.0005259258,0.00006556984,0.0006722907,0.00002871801,0.00007345846],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9673513,"threshold_uncertainty_score":0.808439,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074206824","doi":"10.1185/03007995.2014.907140","title":"Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Hazard ratio; Propensity score matching; Internal medicine; Stroke (engine); Confidence interval; Pulmonary embolism; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.1476086908751722,"gpt":0.4726216408878418,"spread":0.3250129500126696,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00205788,0.00009841614,0.0003780905,0.0003002421,0.00007852538,0.00001527011,0.00003777547,0.00007009444,0.00002324708],"category_scores_gemma":[0.001355043,0.00007677991,0.00003821679,0.0002976934,0.0002749892,0.00008367901,0.0001563682,0.0002307716,0.000002068223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003991032,"about_ca_system_score_gemma":0.00005435455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001226171,"about_ca_topic_score_gemma":0.00003286162,"domain_scores_codex":[0.9980299,0.0004453829,0.0003110067,0.0002562861,0.0007502947,0.0002070721],"domain_scores_gemma":[0.9980717,0.001387273,0.0000587871,0.0001013385,0.0001289911,0.0002518601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001301727,0.0000120545,0.8672453,0.0004374075,0.00001811827,3.547563e-7,0.0001459606,0.000002121975,0.00001606883,0.003774289,0.0000597908,0.1269868],"study_design_scores_gemma":[0.005342601,0.0005310156,0.9751676,0.0006613863,0.000009343118,4.13524e-7,0.00002665808,0.003190745,0.00004339631,0.0008044856,0.01415406,0.00006826883],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970021,0.0008426277,0.0001743417,0.0004748096,0.0002523181,0.0007778223,0.000003798948,0.000009623022,0.0004626125],"genre_scores_gemma":[0.9945257,0.004813252,0.00003535698,0.000002887198,0.0005252701,0.000001552889,0.0000724515,0.000005653892,0.00001787962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1269185,"threshold_uncertainty_score":0.3130994,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097933001","doi":"10.1185/030079903125003125","title":"Efficacy of risedronate on clinical vertebral fractures within six months","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Procter and Gamble","keywords":"Medicine; Osteoporosis; Placebo; Incidence (geometry); Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1660188092593357,"gpt":0.5405479117058117,"spread":0.3745291024464761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004313527,0.0001576967,0.0004841747,0.0002959993,0.0001750722,0.0000206974,0.000223706,0.0003121169,0.0003001156],"category_scores_gemma":[0.01119449,0.0001090496,0.0001179002,0.0003826237,0.001010918,0.00005924566,0.0001769017,0.00257259,0.0001061046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009071044,"about_ca_system_score_gemma":0.001840825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001584922,"about_ca_topic_score_gemma":0.00002728245,"domain_scores_codex":[0.994565,0.0003548406,0.0007464055,0.0004897933,0.003092331,0.0007516828],"domain_scores_gemma":[0.9957217,0.001329383,0.0000827479,0.0003839485,0.0003291093,0.002153093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01012907,0.006052474,0.04333474,0.001506236,0.00007950672,0.0001004652,0.0004750063,0.000005000466,0.0001022421,0.006902459,0.02234136,0.9089714],"study_design_scores_gemma":[0.03253205,0.01968063,0.8336315,0.005977681,0.00001892185,0.00004501292,0.0001938356,0.0007029546,0.001810524,0.003734285,0.1013554,0.0003171383],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792385,0.007132583,0.00004404805,0.01066601,0.0009775473,0.0009672327,0.00001238728,0.00003512831,0.0009266086],"genre_scores_gemma":[0.9876518,0.01100048,0.00008230688,0.0002947699,0.0007976758,0.00003003055,0.00007315026,0.00001946498,0.00005037871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9086543,"threshold_uncertainty_score":0.9997285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064799289","doi":"10.1185/030079905x75087","title":"The economic burden of schizophrenia in Canada in 2004","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"National Institute of Mental Health","keywords":"Medicine; Schizophrenia (object-oriented programming); Government (linguistics); Productivity; Indirect costs; Health care; Unemployment; Economic cost; Psychiatry; MEDLINE; Environmental health; Gerontology; Demography; Economic growth; Business; Accounting","retraction":null,"screen_n_in":null,"score":{"opus":0.0509386803591048,"gpt":0.3887010100075109,"spread":0.3377623296484061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001372908,0.00008674641,0.0002111883,0.0001966479,0.00006621814,0.00001393769,0.0001744916,0.00005073617,0.0001701698],"category_scores_gemma":[0.0009551224,0.00005466547,0.00002442139,0.0002210276,0.0002519842,0.00004326198,0.0001183269,0.0007352636,0.00002196098],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001175491,"about_ca_system_score_gemma":0.009326124,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3964897,"about_ca_topic_score_gemma":0.8704254,"domain_scores_codex":[0.9976873,0.0001488126,0.0003327286,0.0002230938,0.001064447,0.0005436421],"domain_scores_gemma":[0.998448,0.0007016864,0.00002487393,0.0002089721,0.00005842522,0.0005580719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003529082,0.0001228648,0.02769788,0.00009040727,0.00001647971,0.00003956973,0.00006425811,0.00001017725,0.000007036383,0.002101291,0.005823744,0.9604972],"study_design_scores_gemma":[0.03845447,0.001763019,0.6423934,0.003835282,0.000008625643,0.00008947319,0.001096927,0.03401026,0.0009146105,0.005301239,0.2717419,0.0003908917],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9559248,0.02721323,0.000001472526,0.01593904,0.0001976221,0.0004329247,0.000009513702,0.000003542776,0.0002778668],"genre_scores_gemma":[0.9800833,0.01940541,0.00003226371,0.000009359792,0.0003566322,0.00004974472,0.00001908039,0.000006552913,0.00003759088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9601063,"threshold_uncertainty_score":0.9962901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135648839","doi":"10.1185/030079903125002405","title":"Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"AstraZeneca","keywords":"Rosuvastatin; Medicine; Pravastatin; Atorvastatin; Simvastatin; Pharmacology; Statin; Rosuvastatin Calcium; Internal medicine; Cholesterol","retraction":null,"screen_n_in":null,"score":{"opus":0.1761258023841201,"gpt":0.47144030552235,"spread":0.2953145031382299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007508124,0.000149912,0.0005730429,0.00008861449,0.0001547795,0.0000235218,0.000195783,0.0001109557,0.00002951648],"category_scores_gemma":[0.02734737,0.00008371905,0.00011043,0.0005046825,0.000653847,0.00004324728,0.0001729022,0.001050647,0.0000014003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004339345,"about_ca_system_score_gemma":0.0007995841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004720299,"about_ca_topic_score_gemma":0.0001111093,"domain_scores_codex":[0.994148,0.001834146,0.0009057327,0.0003804774,0.002308203,0.0004234332],"domain_scores_gemma":[0.9926787,0.005977313,0.0002280454,0.0005268216,0.0002354964,0.0003536425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04531173,0.001660968,0.03772465,0.0009355238,0.0001792046,0.00000620842,0.006713731,0.000007035668,0.0002371619,0.001340201,0.003753063,0.9021305],"study_design_scores_gemma":[0.434035,0.01173767,0.3597246,0.01218583,0.0001763064,0.00001613329,0.0160651,0.002933193,0.005322815,0.0006015897,0.156581,0.0006208248],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845405,0.01143612,0.0001501306,0.001400896,0.0006935757,0.001544253,0.00006720264,0.000006636962,0.0001607316],"genre_scores_gemma":[0.9949762,0.004340578,0.0002098414,0.00001823204,0.0003560629,0.00002702255,0.00005040919,0.00001477656,0.00000693549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9015097,"threshold_uncertainty_score":0.9808457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3185110408","doi":"10.1080/03007995.2021.1957807","title":"Cognitive function improvement after fecal microbiota transplantation in Alzheimer’s dementia patient: a case report","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Research Foundation of Korea","keywords":"Medicine; Dementia; Fecal bacteriotherapy; Cognition; Transplantation; Intensive care medicine; Gerontology; Psychiatry; Internal medicine; Disease; Clostridium difficile; Antibiotics","retraction":null,"screen_n_in":null,"score":{"opus":0.08422120638097003,"gpt":0.4074498642254518,"spread":0.3232286578444817,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001016353,0.0001580695,0.0002439033,0.0002821535,0.0001357996,0.00005459088,0.00004564799,0.0001712513,0.0008087545],"category_scores_gemma":[0.0008553005,0.0001389228,0.00007247795,0.0005504417,0.0002295705,0.00008085263,0.0001427396,0.001021333,0.00003349014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008053694,"about_ca_system_score_gemma":0.0008154996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001636586,"about_ca_topic_score_gemma":0.0002193098,"domain_scores_codex":[0.9966564,0.0002140214,0.0004894563,0.0005967739,0.001430808,0.0006125825],"domain_scores_gemma":[0.9983091,0.0002691887,0.00004035981,0.0001992979,0.000540618,0.0006414414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00340522,0.002055196,0.00516248,0.0007317077,0.0003594128,0.09812154,0.0005100137,9.944116e-8,0.005869274,0.00004552689,0.001418973,0.8823206],"study_design_scores_gemma":[0.05902579,0.02186302,0.1003274,0.02137538,0.002247955,0.2196525,0.01151714,0.002822567,0.4190508,0.0006358063,0.1389696,0.002512058],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.965165,0.03198651,0.000136697,0.001247887,0.0004625222,0.0006835148,0.00004949991,0.00001698519,0.0002513423],"genre_scores_gemma":[0.9895976,0.009085381,0.00001378231,0.00006889246,0.0002899427,0.0001738908,0.0007345295,0.00001624101,0.00001975518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8798085,"threshold_uncertainty_score":0.8855294,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2022069934","doi":"10.1185/03007995.2011.621416","title":"Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Management and Education","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia; University of Calgary","funders":"Novo Nordisk Canada","keywords":"Medicine; Glycemic; Hypoglycemia; Intensive care medicine; Insulin; Type 2 diabetes; Diabetes mellitus; Diabetes management; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.09655757236718554,"gpt":0.3900579780538292,"spread":0.2935004056866437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000915067,0.0000714876,0.0001658202,0.000182134,0.000056072,0.000007532523,0.0001066165,0.00004442274,0.000240725],"category_scores_gemma":[0.00284832,0.00004283122,0.00002791604,0.0003949043,0.0002394935,0.00003971883,0.00004638009,0.0002050277,0.00002596562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007390291,"about_ca_system_score_gemma":0.0002083047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005612789,"about_ca_topic_score_gemma":0.000008933149,"domain_scores_codex":[0.9987882,0.0001424116,0.0001426556,0.0001762838,0.0004571971,0.0002932581],"domain_scores_gemma":[0.998918,0.0003465724,0.00002142873,0.0001350585,0.0001218881,0.0004570665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001940542,0.000515617,0.2580014,0.0003181573,0.00007037759,0.000002277775,0.003880639,1.296868e-7,0.0001862126,0.0005539346,0.002601563,0.7319292],"study_design_scores_gemma":[0.01175211,0.01938266,0.8815456,0.002979453,0.00007702533,0.000001625633,0.0039295,0.002755916,0.00205936,0.001335374,0.07391528,0.0002661084],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904882,0.004918773,0.00001018459,0.002287492,0.0004422904,0.0009385393,0.000002797385,0.000007132106,0.0009045972],"genre_scores_gemma":[0.9975169,0.00208617,0.000008634473,0.0001124208,0.0001181954,0.0001071051,0.00001202773,0.000005038852,0.00003351426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.731663,"threshold_uncertainty_score":0.3409911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973734746","doi":"10.1185/030079906x132415","title":"Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; PharmIdeas (Canada)","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Adverse effect; Rating scale; Confidence interval; Depression (economics); Hamd; Randomized controlled trial; Clinical trial; Psychiatry; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.361541639911768,"gpt":0.5620345049789328,"spread":0.2004928650671648,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006617029,0.0005153581,0.006203244,0.002492967,0.0001337912,0.00002970555,0.0002391429,0.0004979814,0.0002942794],"category_scores_gemma":[0.01019202,0.0002999345,0.001217955,0.00201681,0.0003287967,0.0001019678,0.0003564239,0.001439842,0.00001196441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001796249,"about_ca_system_score_gemma":0.0007215267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008543666,"about_ca_topic_score_gemma":0.0003162604,"domain_scores_codex":[0.9911148,0.002662125,0.001910389,0.001097546,0.00261298,0.00060218],"domain_scores_gemma":[0.9931911,0.00420899,0.000550738,0.0006474463,0.0003018627,0.001099912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004107068,0.001057506,0.001120502,0.01199644,0.01133224,0.00004549962,0.00007193079,2.668962e-7,0.000005027454,0.00002937228,0.005128729,0.9688018],"study_design_scores_gemma":[0.003204921,0.0004035779,0.001821911,0.01684584,0.06060835,0.00001951982,0.00004538844,0.00006991481,0.00001134995,0.000100271,0.9165871,0.0002818759],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009699248,0.9946879,0.0000342275,0.001057901,0.0002174755,0.002767104,0.000159456,0.00002410563,0.00008189934],"genre_scores_gemma":[0.0007476272,0.9964733,0.00006180306,0.000009726708,0.0002217191,0.000509739,0.001619696,0.00004002245,0.0003163432],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9685199,"threshold_uncertainty_score":0.9999453,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129953844","doi":"10.1185/03007990802622726","title":"Escitalopram in the treatment of major depressive disorder: A meta-analysis","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company","keywords":"Escitalopram; Citalopram; Duloxetine; Venlafaxine; Major depressive disorder; Sertraline; Medicine; Internal medicine; Antidepressant; Paroxetine; Fluoxetine; Rating scale; Meta-analysis; Hamilton Rating Scale for Depression; Depression (economics); Psychiatry; Psychology; Serotonin","retraction":null,"screen_n_in":null,"score":{"opus":0.3728428615273289,"gpt":0.5338162859527834,"spread":0.1609734244254545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009408066,0.0004427801,0.003647831,0.001123361,0.0001429705,0.00002635867,0.0003928243,0.0003745366,0.0003467285],"category_scores_gemma":[0.0009629555,0.0001928371,0.001927736,0.001715914,0.0005837458,0.00004849484,0.0001321778,0.0009056101,0.00002405338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001535986,"about_ca_system_score_gemma":0.0006892921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001843309,"about_ca_topic_score_gemma":0.00006724907,"domain_scores_codex":[0.993583,0.001263768,0.0008669813,0.0007260324,0.003004264,0.0005560184],"domain_scores_gemma":[0.9957051,0.002594073,0.0002235817,0.000840313,0.0001487088,0.0004882759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005343221,0.003314507,0.0003098099,0.003880521,0.02024544,0.0001356255,0.0002082173,4.884749e-8,1.389253e-8,0.00005257561,0.0009512567,0.9708486],"study_design_scores_gemma":[0.001575574,0.001357639,0.0002734066,0.002370071,0.04303292,0.00008211366,0.00003332844,0.00001617371,4.998714e-7,0.00004979457,0.9510732,0.0001353182],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007790096,0.9966488,0.00002532177,0.0005979752,0.0001163964,0.002280123,0.00008657558,0.00001308136,0.0001538023],"genre_scores_gemma":[0.0002561739,0.9973814,0.00002460532,0.000005918605,0.000195397,0.001128676,0.0008808819,0.00002549913,0.0001014735],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9707133,"threshold_uncertainty_score":0.7863668,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155850242","doi":"10.1185/03007990903069249","title":"Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; The Scarborough Hospital","funders":"Temple University","keywords":"Medicine; Internal medicine; Creatinine; Uric acid; Placebo; Kidney disease; Blood urea nitrogen; Gastroenterology; Probiotic; Clinical trial; Crossover study; Renal function; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.03312535570918103,"gpt":0.3632865502161355,"spread":0.3301611945069545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003470182,0.00008360834,0.0001069289,0.00006634949,0.0000548697,0.00001450785,0.00007432317,0.00003597424,0.0000272128],"category_scores_gemma":[0.000138001,0.0000661785,0.000006856699,0.0001066235,0.00007929056,0.000006510146,0.00005458935,0.000236189,4.194681e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001536485,"about_ca_system_score_gemma":0.00283794,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0207273,"about_ca_topic_score_gemma":0.266249,"domain_scores_codex":[0.9986739,0.0001227022,0.0001755988,0.0002815449,0.0003855391,0.0003607631],"domain_scores_gemma":[0.99931,0.00001648583,0.0000230405,0.0001012103,0.00003952924,0.0005097092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04610677,0.002367582,0.7966631,0.001063481,0.00001509534,0.00001455497,0.0001179714,0.000002851594,0.002503752,0.0000499158,0.01789138,0.1332035],"study_design_scores_gemma":[0.03343282,0.005783153,0.9499019,0.0004125854,0.000001616368,3.07809e-7,0.00003186614,0.0001227647,0.0001005661,0.00002302581,0.01006394,0.0001254906],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958711,0.001909666,0.000005123876,0.001249019,0.000114882,0.000763751,0.00007280799,0.000001401215,0.00001220948],"genre_scores_gemma":[0.9958289,0.002686501,0.000007380296,0.00008667017,0.0001188678,0.00002105042,0.001231443,0.000004647649,0.00001449828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2455217,"threshold_uncertainty_score":0.9857938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3080596765","doi":"10.1080/03007995.2020.1815682","title":"Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"AstraZeneca","keywords":"Medicine; Chronic rhinosinusitis; Epidemiology; Nasal polyps; Intensive care medicine; Dermatology; Clinical epidemiology; Systematic review; Sinusitis; MEDLINE; Internal medicine; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.187408076042334,"gpt":0.5285382074559681,"spread":0.3411301314136341,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004629826,0.0002566135,0.003475527,0.0001675035,0.00009033842,0.000009716738,0.0002986021,0.0004124596,0.00008230384],"category_scores_gemma":[0.01548955,0.0001209303,0.0004190467,0.0008308645,0.001279643,0.00003265672,0.0003339298,0.002179869,0.000004511437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007316583,"about_ca_system_score_gemma":0.001808643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001295489,"about_ca_topic_score_gemma":0.000002484985,"domain_scores_codex":[0.9936079,0.002805194,0.001650681,0.0004689468,0.001113962,0.0003533227],"domain_scores_gemma":[0.9929475,0.004949512,0.0005463915,0.0004667022,0.0004056158,0.0006842425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00001548879,0.0000671538,0.00007820382,0.6832938,0.0001683461,0.00001779473,0.00001568448,3.803188e-10,3.229385e-8,0.0004352016,0.003759184,0.3121492],"study_design_scores_gemma":[0.0003980557,0.001112238,0.0001929502,0.7785091,0.0004732494,0.0004752026,0.000005500958,0.00001502516,8.664891e-8,0.00001286744,0.2187293,0.00007640102],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002141019,0.9953774,0.00001467165,0.001821381,0.0003702577,0.00221306,0.000130372,0.000007806877,0.000043592],"genre_scores_gemma":[0.00007065089,0.9985691,0.00001788675,0.00008774069,0.0008817965,0.00009545321,0.0002346732,0.00002128831,0.0000213541],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3120728,"threshold_uncertainty_score":0.9928034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167525817","doi":"10.1185/03007995.2014.982246","title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ulipristal acetate; Hysterectomy; Uterine artery embolization; Uterine fibroids; Leiomyoma; Endometrial ablation; Cochrane Library; Systematic review; Watchful waiting; Review article; Intensive care medicine; General surgery; MEDLINE; Surgery; Randomized controlled trial; Population; Internal medicine; Family planning; Pathology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.2280167979989725,"gpt":0.5297126304550334,"spread":0.3016958324560609,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001402561,0.0004658308,0.001944438,0.0005022608,0.0001053633,0.00002210312,0.0003374647,0.0003882182,0.0007818965],"category_scores_gemma":[0.0003506984,0.0002920235,0.0003428467,0.0003908116,0.0003748882,0.00003947562,0.0005795264,0.001071754,0.0001114734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001502899,"about_ca_system_score_gemma":0.0006383561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003430968,"about_ca_topic_score_gemma":6.409663e-7,"domain_scores_codex":[0.9937657,0.0003876075,0.0009560309,0.000739703,0.003534909,0.000616118],"domain_scores_gemma":[0.9971879,0.0004801276,0.0001909504,0.0005868986,0.0001092181,0.001444953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000126377,0.001038709,0.00005345088,0.04909119,0.0006494726,0.0004275593,0.00001066521,1.060901e-9,1.936147e-8,0.0007468218,0.007465338,0.9403904],"study_design_scores_gemma":[0.002726534,0.002233562,0.00008437684,0.1099491,0.0001133998,0.0000876331,0.000008010303,0.00001953434,0.000001139857,0.00009726973,0.884519,0.0001604304],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007828857,0.9921055,0.00004349191,0.0008132296,0.0006967317,0.001447447,0.00005780716,0.00003523686,0.004722234],"genre_scores_gemma":[0.0007795824,0.9968051,0.00004183896,0.00001495764,0.0006133919,0.000264099,0.0007120493,0.00005305219,0.0007159676],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.94023,"threshold_uncertainty_score":0.9999532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103796156","doi":"10.1185/030079902125000282","title":"Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Etoricoxib; Osteoarthritis; Placebo; Randomized controlled trial; Clinical trial; Internal medicine; Anesthesia; Adverse effect; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08160137811245635,"gpt":0.373905642709058,"spread":0.2923042645966016,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003236545,0.0002290696,0.001362024,0.000293351,0.000113136,0.00003325465,0.00008612757,0.0001927526,0.0001636673],"category_scores_gemma":[0.00437048,0.0001474916,0.0000662244,0.000256788,0.0009829366,0.0001140334,0.00009818486,0.0008855393,0.000005608615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005291013,"about_ca_system_score_gemma":0.000195384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000193845,"about_ca_topic_score_gemma":0.000008881505,"domain_scores_codex":[0.9960079,0.0008297372,0.0006735806,0.0004855387,0.001497139,0.0005061412],"domain_scores_gemma":[0.9955294,0.003039437,0.0001370495,0.0002176349,0.0002482297,0.0008282508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9168375,0.002384229,0.00712724,0.0004475163,0.00005225122,0.000008468844,0.0005252979,6.996776e-8,0.000006013935,0.00007299049,0.0002625808,0.0722758],"study_design_scores_gemma":[0.9733962,0.006533018,0.01743536,0.001245235,0.00003293489,0.000004438708,0.00003841448,0.0004982912,0.00007490827,0.00001587951,0.0005869329,0.0001384061],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854802,0.00437226,0.000007736377,0.0002488442,0.0003860113,0.009300507,0.000009368556,0.00001667617,0.000178348],"genre_scores_gemma":[0.9974621,0.001493049,0.0000145367,0.000008968776,0.0003531795,0.0005908089,0.00004329534,0.00001548051,0.00001859609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07213739,"threshold_uncertainty_score":0.6014534,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146473798","doi":"10.1185/030079907x210444","title":"The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature","year":2007,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"AstraZeneca","keywords":"Medicine; Modified Rankin Scale; Barthel index; Stroke (engine); Term (time); Scale (ratio); Physical therapy; Index (typography); Physical medicine and rehabilitation; Intensive care medicine; Internal medicine; Activities of daily living; Ischemic stroke","retraction":null,"screen_n_in":null,"score":{"opus":0.2058010798113732,"gpt":0.5485744398505992,"spread":0.342773360039226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005609196,0.0002902591,0.001258881,0.0002056767,0.0001891422,0.00008961082,0.0002664453,0.0003547679,0.00004021022],"category_scores_gemma":[0.02473436,0.0001202369,0.0005420569,0.0004398111,0.001051353,0.0000749626,0.000207798,0.001487397,0.000004148135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000639697,"about_ca_system_score_gemma":0.0009196321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001994628,"about_ca_topic_score_gemma":0.000004039545,"domain_scores_codex":[0.9953467,0.00110837,0.0008534728,0.0004271687,0.001794239,0.0004700205],"domain_scores_gemma":[0.9834055,0.01492978,0.0002049306,0.0004136231,0.0005966505,0.0004495501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001622571,0.0001074069,0.001292389,0.1689716,0.00009485074,0.000001971084,0.0003462293,4.958305e-10,2.173752e-8,0.0001990996,0.0006870385,0.8281371],"study_design_scores_gemma":[0.001065923,0.0004122858,0.00759065,0.4031166,0.0001377755,0.00003307759,0.0001151073,0.000002691531,2.450388e-7,0.0002010413,0.5871981,0.0001265477],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006107718,0.9909567,0.00007893857,0.001990653,0.000703951,0.005423922,0.0001451541,0.000008239969,0.0000816742],"genre_scores_gemma":[0.0003912488,0.9976652,0.00001457888,0.0001068192,0.0003094732,0.0008913035,0.0001758144,0.00002318721,0.0004224013],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8280106,"threshold_uncertainty_score":0.9834807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3010977327","doi":"10.1080/03007995.2020.1744120","title":"Use of dienogest in endometriosis: a narrative literature review and expert commentary","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Bayer","keywords":"Dienogest; Endometriosis; Medicine; Context (archaeology); Narrative review; Quality of life (healthcare); Pelvic pain; General surgery; Intensive care medicine; Gynecology; Surgery; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.284007940273055,"gpt":0.5318228009939459,"spread":0.2478148607208908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00173381,0.0003956413,0.002715064,0.00135607,0.00008668889,0.00005898517,0.0002161043,0.0002915135,0.0001260439],"category_scores_gemma":[0.03416439,0.000245737,0.0002378511,0.003111146,0.0005502146,0.0001399861,0.0005539053,0.002569659,0.00000697953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002298385,"about_ca_system_score_gemma":0.0006674127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005074559,"about_ca_topic_score_gemma":0.000009080369,"domain_scores_codex":[0.9945158,0.001227999,0.0008809302,0.0007019396,0.002044944,0.0006283437],"domain_scores_gemma":[0.989498,0.008136996,0.0001431929,0.0003546343,0.0003025364,0.001564595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008081253,0.0005861212,0.00005522783,0.1193764,0.0001817696,0.000235536,0.0002639505,1.632403e-10,1.227333e-7,0.00003049738,0.02292961,0.8562599],"study_design_scores_gemma":[0.0009935554,0.001183383,0.00001720698,0.2902516,0.0000695725,0.00009963416,0.00003496204,0.000001656898,8.718672e-7,0.000007249727,0.7072332,0.0001072008],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008980875,0.9890928,0.000001536511,0.007363302,0.0001136857,0.003241007,0.0001430925,0.00001134182,0.00002426247],"genre_scores_gemma":[0.00001898481,0.9978176,0.00005366592,0.0003124384,0.0002439294,0.0006448309,0.0008627741,0.00003037687,0.00001544568],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8561527,"threshold_uncertainty_score":0.9999995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973651333","doi":"10.1185/03007995.2010.547575","title":"Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Infliximab; Adverse effect; Crohn's disease; Internal medicine; Clinical trial; Randomized controlled trial; Disease; Inflammatory bowel disease; Physical therapy; Pediatrics","retraction":null,"screen_n_in":null,"score":{"opus":0.07697412502220531,"gpt":0.3890091897877285,"spread":0.3120350647655232,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001059059,0.0001232185,0.0001623094,0.00008134143,0.00009882041,0.00002311785,0.0002915692,0.0001003647,0.00001780461],"category_scores_gemma":[0.001456932,0.00009949767,0.00002317533,0.00008799094,0.0002573845,0.00001217445,0.0004172949,0.0001856335,0.000001602053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000151637,"about_ca_system_score_gemma":0.000320965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002734375,"about_ca_topic_score_gemma":0.000008717613,"domain_scores_codex":[0.9984206,0.0001555723,0.0002570368,0.0004544803,0.0003510127,0.0003612787],"domain_scores_gemma":[0.9987901,0.00005233127,0.00003895379,0.0002883174,0.0002051632,0.0006251658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1373522,0.00585933,0.1938613,0.0006396223,0.0001086411,0.0000735073,0.0006658215,0.000008993381,0.003730667,0.004751233,0.01063385,0.6423149],"study_design_scores_gemma":[0.0104445,0.0005722496,0.9831938,0.0003581014,0.000002409561,0.000002962535,0.00001546219,0.0006034526,0.000404834,0.0007063913,0.003530123,0.0001657318],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931557,0.004550705,0.0005082045,0.0001818465,0.00009075383,0.001377479,0.00006875381,0.000003999241,0.00006262492],"genre_scores_gemma":[0.9910253,0.008283574,0.0001497041,0.00008128995,0.0001096804,0.0001132846,0.0001880307,0.0000162543,0.00003290482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7893324,"threshold_uncertainty_score":0.4057398,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2148461943","doi":"10.1185/030079904x2114","title":"Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Cilag","keywords":"Medicine; Fentanyl; Adverse effect; Cancer pain; Somnolence; Morphine; Constipation; Transdermal; Chronic pain; Internal medicine; Randomized controlled trial; Cancer; Anesthesia; Incidence (geometry); Physical therapy; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.03037748228040237,"gpt":0.3727621874962481,"spread":0.3423847052158457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107734,0.0001419303,0.0002943149,0.0002034189,0.00008287087,0.00001737114,0.00005993636,0.00007682574,0.00006457294],"category_scores_gemma":[0.0003162183,0.0001002008,0.00001383307,0.0002657861,0.0005806249,0.00008799871,0.0000959816,0.0004532645,3.039578e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001100221,"about_ca_system_score_gemma":0.0003185923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002735584,"about_ca_topic_score_gemma":0.0001921202,"domain_scores_codex":[0.9981373,0.00009384713,0.0002376291,0.0003256914,0.0007926694,0.0004128589],"domain_scores_gemma":[0.9990675,0.0001760934,0.00003446373,0.0001080742,0.0001020152,0.000511868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002974716,0.0005242863,0.6269228,0.001931455,0.00004241824,0.00001689133,0.0003584175,0.000003341089,0.00002406979,0.000163306,0.0003871452,0.3666512],"study_design_scores_gemma":[0.02477505,0.001611012,0.9659029,0.003045605,0.00001988369,5.678828e-7,0.0001095771,0.001256109,0.00002709756,0.00008102273,0.003049621,0.0001215841],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805359,0.01450205,0.0002120913,0.00375866,0.00006421147,0.0008882515,0.00001489008,0.000007633583,0.00001631604],"genre_scores_gemma":[0.9550034,0.04465623,0.00002524416,0.00006203558,0.0001258714,0.00004177643,0.00005406831,0.00001164756,0.00001966278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3665296,"threshold_uncertainty_score":0.4086071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073695555","doi":"10.1185/03007995.2013.812961","title":"Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Atomoxetine; Medicine; Methylphenidate; Attention deficit hyperactivity disorder; Psychiatry; Stimulant; MEDLINE; Population; European union; Epidemiology; Pediatrics; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.3117459813348096,"gpt":0.5198673718540309,"spread":0.2081213905192213,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00215676,0.0004126777,0.0009156317,0.0003798977,0.0003163547,0.0001344231,0.0002154474,0.0001903422,0.000140975],"category_scores_gemma":[0.00416557,0.0002350925,0.0002082325,0.0005098966,0.0002409063,0.0002234144,0.0002130474,0.001099641,0.00009131643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001432199,"about_ca_system_score_gemma":0.0004723459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002897393,"about_ca_topic_score_gemma":0.00007212406,"domain_scores_codex":[0.9940972,0.002141898,0.0007536752,0.0007830841,0.00172214,0.0005019939],"domain_scores_gemma":[0.9975153,0.0008044303,0.000171987,0.0005245354,0.0003998214,0.0005839717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002269327,0.0007533942,0.07882997,0.01031498,0.0000285704,0.00002243054,0.00001443096,5.907524e-8,4.749261e-8,0.0001086732,0.0003425888,0.9095622],"study_design_scores_gemma":[0.001362216,0.0002701629,0.1706462,0.02857562,0.0002254378,0.00008875426,0.0001999716,0.0002574481,2.105833e-9,0.00004767103,0.7980345,0.000291979],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03097302,0.9631646,0.00003668595,0.00285913,0.0003136465,0.002451868,0.00004037454,0.00002990095,0.0001307721],"genre_scores_gemma":[0.005794165,0.9917908,0.00001253065,0.00001818079,0.000688924,0.0005030934,0.0009603017,0.0000452811,0.000186698],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9092702,"threshold_uncertainty_score":0.9586793,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165140611","doi":"10.1185/030079906x162674","title":"Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Tramadol; Acetaminophen; Peripheral neuropathy; Placebo; Randomized controlled trial; Peripheral; Diabetic neuropathy; Anesthesia; Internal medicine; Diabetes mellitus; Analgesic","retraction":null,"screen_n_in":null,"score":{"opus":0.09226693513633698,"gpt":0.4176050997037606,"spread":0.3253381645674236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003296041,0.0001414064,0.0005770508,0.0002308532,0.00006622358,0.00001663305,0.0001041383,0.00008522061,0.0001266802],"category_scores_gemma":[0.002188964,0.00009949099,0.00006617985,0.000291568,0.0002822508,0.00003990489,0.00008516776,0.0005369614,0.000006310049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006597284,"about_ca_system_score_gemma":0.0001682932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000269699,"about_ca_topic_score_gemma":0.00004757554,"domain_scores_codex":[0.9963409,0.001043479,0.0004234063,0.0003258401,0.001429207,0.0004372107],"domain_scores_gemma":[0.9980618,0.001250778,0.00004782357,0.0001979443,0.0001023093,0.0003393805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4680647,0.02894258,0.1297982,0.00144362,0.0002932872,0.0006642119,0.003096501,0.000006846918,0.0003965428,0.003713276,0.001735916,0.3618443],"study_design_scores_gemma":[0.9247309,0.006336272,0.05872346,0.0008547559,0.00005049405,0.000008076551,0.0009111046,0.005744696,0.0001249321,0.001159268,0.001176132,0.0001798871],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939584,0.003075128,0.00007982984,0.0003575484,0.0004477577,0.001660512,0.000002521532,0.00001567923,0.0004026255],"genre_scores_gemma":[0.9984119,0.00108123,0.00002510514,0.000008438089,0.0001982099,0.0001643649,0.00003621312,0.00001268229,0.00006188604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4566663,"threshold_uncertainty_score":0.4057125,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129945276","doi":"10.1185/030079905x43677","title":"Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Metabolic syndrome; Position paper; Diabetes mellitus; Type 2 diabetes; Position (finance); Consensus conference; Intensive care medicine; Internal medicine; Endocrinology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1107468488955015,"gpt":0.3911863697184043,"spread":0.2804395208229028,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006752674,0.0003349997,0.001558808,0.0003013141,0.0001090922,0.00005179578,0.0002741191,0.000215113,0.00004131432],"category_scores_gemma":[0.0007563861,0.0001927043,0.0001903717,0.0007602662,0.0005543363,0.00004587904,0.0002223547,0.001405626,0.00001140842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007459768,"about_ca_system_score_gemma":0.000342891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003181766,"about_ca_topic_score_gemma":0.00001953636,"domain_scores_codex":[0.9942046,0.001941141,0.0006752117,0.0005500758,0.001985834,0.0006431781],"domain_scores_gemma":[0.9983341,0.0005536599,0.0001707724,0.0003982749,0.0001444661,0.0003987206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002107135,0.0002892936,0.00006460163,0.009621778,0.0007164974,0.00006802801,0.00007606214,6.065314e-9,2.570217e-7,0.00004237259,0.001017155,0.9880829],"study_design_scores_gemma":[0.002358144,0.0005016488,0.01127096,0.06982383,0.0006597302,0.00009439406,0.0001140758,0.000007038764,0.000001530786,0.00001431989,0.9149079,0.0002464829],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008752227,0.9884849,0.000004801883,0.0003175792,0.0001062342,0.001855717,0.00004984652,0.00001855009,0.0004101711],"genre_scores_gemma":[0.008827508,0.9899703,0.00003396312,0.00004087029,0.0001582356,0.0002058203,0.0006848768,0.00004350259,0.0000348944],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9878364,"threshold_uncertainty_score":0.7858255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131806746","doi":"10.1185/030079904125004178","title":"Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"AstraZeneca","keywords":"Migraine; Medicine; Zolmitriptan; Menstruation; Physical therapy; Migraine treatment; Pediatrics; Psychiatry; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.194414882329176,"gpt":0.5139342092231748,"spread":0.3195193268939988,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004001263,0.0001733114,0.0003641898,0.0002103742,0.0001941283,0.00001816377,0.00008360879,0.00009055211,0.00005536155],"category_scores_gemma":[0.006767815,0.00008750506,0.00007238345,0.0003442042,0.0007729154,0.00004817888,0.0001263559,0.0005421595,0.000001747426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007440338,"about_ca_system_score_gemma":0.000387406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001111079,"about_ca_topic_score_gemma":0.0003714406,"domain_scores_codex":[0.9973401,0.0003383612,0.0003248091,0.0003142597,0.001312771,0.0003696446],"domain_scores_gemma":[0.9977782,0.0009130134,0.0000620148,0.0002049129,0.0005835,0.000458363],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004332596,0.003877774,0.1743687,0.000671859,0.0003492677,0.000003515193,0.01078684,4.575119e-7,0.0002815636,0.0004371585,0.04660561,0.7582847],"study_design_scores_gemma":[0.02064664,0.008657442,0.9590102,0.00107134,0.00002666194,0.000008148159,0.0008839726,0.0008103566,0.00008869201,0.0008429163,0.007814737,0.0001388557],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823175,0.01429947,0.00003139081,0.002195399,0.00005400688,0.0008749875,0.00007580329,0.000008764187,0.0001426706],"genre_scores_gemma":[0.9775243,0.02189474,0.000004397401,0.0000501685,0.0001792741,0.00003384534,0.0002743022,0.000009646024,0.00002929047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7846416,"threshold_uncertainty_score":0.8102196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020989669","doi":"10.1185/03007991003771338","title":"Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Research in Astrophysics of Québec","funders":"","keywords":"Omalizumab; Medicine; Placebo; Asthma; Exacerbation; Adverse effect; Immunoglobulin E; Randomized controlled trial; Rate ratio; Internal medicine; Corticosteroid; Anesthesia; Gastroenterology; Confidence interval; Immunology; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.03495446278182664,"gpt":0.372221480296493,"spread":0.3372670175146664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196155,0.0001922989,0.0004549678,0.0003426691,0.0001413432,0.000039363,0.0001855428,0.0002272324,0.000697631],"category_scores_gemma":[0.002305311,0.0001179538,0.00006344304,0.0003345708,0.0006637628,0.00009240571,0.0001235116,0.001770366,0.00007691432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003711174,"about_ca_system_score_gemma":0.001061179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005509951,"about_ca_topic_score_gemma":0.0001233537,"domain_scores_codex":[0.9965306,0.0002099179,0.0003402866,0.0004410926,0.001814065,0.0006640564],"domain_scores_gemma":[0.9977242,0.0003687952,0.00004970601,0.0002642719,0.0002062555,0.00138682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00632767,0.001928335,0.5291196,0.0002810814,0.000103503,0.000208756,0.0001953866,6.147444e-7,0.000121823,0.000847905,0.00538856,0.4554767],"study_design_scores_gemma":[0.0398825,0.002840167,0.8413759,0.001135754,0.00001313838,0.0003638273,0.000172524,0.001139908,0.00004379779,0.0002247266,0.1124832,0.0003245693],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904029,0.005473418,0.00002230342,0.002038212,0.0002764177,0.001051456,0.00001325171,0.00004150037,0.000680582],"genre_scores_gemma":[0.9963853,0.002448795,0.00001926632,0.0001094812,0.000656265,0.0001201109,0.0001545643,0.00002163005,0.00008452529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4551522,"threshold_uncertainty_score":0.7691458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1972258960","doi":"10.1185/03007995.2011.585396","title":"Impact of weight gain on outcomes in type 2 diabetes","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"U.S. National Library of Medicine; Novo Nordisk","keywords":"Medicine; Weight gain; Type 2 diabetes; Weight loss; Internal medicine; Metformin; Glycemic; Type 2 Diabetes Mellitus; Insulin; Insulin resistance; Diabetes mellitus; Endocrinology; Overweight; Liraglutide; Obesity; Body weight","retraction":null,"screen_n_in":null,"score":{"opus":0.2090439553493897,"gpt":0.4992074150971825,"spread":0.2901634597477928,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003116382,0.0003460997,0.002480548,0.0008561665,0.00004158438,0.00001585157,0.0002926764,0.0004567372,0.0004483775],"category_scores_gemma":[0.004499057,0.0002025307,0.0008021789,0.0006549094,0.0004186837,0.00004082313,0.0001987022,0.00190128,0.0001030563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001652249,"about_ca_system_score_gemma":0.001315987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004585113,"about_ca_topic_score_gemma":0.00001740618,"domain_scores_codex":[0.995792,0.0006424175,0.0006493576,0.0005090922,0.001677808,0.0007292901],"domain_scores_gemma":[0.99751,0.0007761038,0.000110348,0.0005947406,0.000200815,0.0008079987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004296271,0.0005760787,0.002078001,0.01337195,0.0003363227,0.00001108757,0.00002549549,5.892968e-9,1.996729e-8,0.0000855221,0.002201834,0.9812707],"study_design_scores_gemma":[0.0009793295,0.002079322,0.009676331,0.04931545,0.00009182677,0.000004319378,0.000003708258,0.000005986168,0.000001277204,0.0001336749,0.9375221,0.0001867198],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002028136,0.9954401,0.000001665993,0.00003678969,0.0007088382,0.001137353,0.0000330694,0.00001597775,0.0005980753],"genre_scores_gemma":[0.0007715547,0.998198,0.000007152635,0.000005532382,0.0005463472,0.00009915521,0.0002668293,0.00004133907,0.00006412924],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.981084,"threshold_uncertainty_score":0.8260221,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971352874","doi":"10.1185/030079903125002450","title":"Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors","year":2003,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Cholinesterase; Rivastigmine; Disease; Donepezil; Alzheimer's disease; Pharmacology; Intensive care medicine; Internal medicine; Dementia","retraction":null,"screen_n_in":null,"score":{"opus":0.2977216713706416,"gpt":0.5340669825974191,"spread":0.2363453112267775,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005588975,0.0004510896,0.001671605,0.0004228483,0.0001564203,0.00008427682,0.0001376723,0.0002109854,0.00006277891],"category_scores_gemma":[0.000809714,0.0002933713,0.0005167757,0.0003449745,0.0002916843,0.0001192848,0.0000651061,0.0004540335,0.000005262445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007002907,"about_ca_system_score_gemma":0.002888517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001142132,"about_ca_topic_score_gemma":0.000003200111,"domain_scores_codex":[0.9963446,0.0004086972,0.0008638848,0.0006902022,0.001148266,0.0005443856],"domain_scores_gemma":[0.9967203,0.0008664714,0.0002043812,0.0003910152,0.000428667,0.001389231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002330927,0.00125508,0.0001279941,0.02135227,0.0001792536,0.00004181893,0.00005046608,3.089805e-8,0.00000198348,0.0003283297,0.002125823,0.9743038],"study_design_scores_gemma":[0.002114835,0.0009222566,0.00004626547,0.02751607,0.0005836898,0.0000201953,0.00004776895,0.00002794655,0.00001825817,0.00008421242,0.9683967,0.0002217713],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001736982,0.9942699,0.00006001816,0.0001533103,0.0007848745,0.002662674,0.0002789026,0.00002136728,0.00003199171],"genre_scores_gemma":[0.0006944661,0.9953662,0.00001281924,0.00001838751,0.001607811,0.0006947829,0.001519147,0.000052116,0.00003430554],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9740821,"threshold_uncertainty_score":0.9999518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082548427","doi":"10.1185/030079905x36396","title":"Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Blepharospasm; Cervical dystonia; Medicine; Hemifacial spasm; Botulinum toxin; Anesthesia; Dystonia; Focal dystonia; Visual analogue scale; Surgery; Facial nerve","retraction":null,"screen_n_in":null,"score":{"opus":0.02722865630179253,"gpt":0.3876719189177403,"spread":0.3604432626159477,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001397427,0.000132063,0.0004176661,0.00009241536,0.00008527582,0.000009916371,0.00005617694,0.0002586538,0.0000747574],"category_scores_gemma":[0.001144316,0.00008751605,0.00005433786,0.0001184717,0.0004131684,0.00006334553,0.0001118978,0.0005758848,0.000001413194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001779373,"about_ca_system_score_gemma":0.00007326048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000296361,"about_ca_topic_score_gemma":0.000007816887,"domain_scores_codex":[0.9981894,0.0002102063,0.0003487768,0.0003365569,0.0006439487,0.0002710532],"domain_scores_gemma":[0.9979445,0.001415487,0.00005651049,0.00010669,0.00009087256,0.0003859258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01729162,0.0005922683,0.154653,0.003429897,0.0001073284,0.00001438223,0.0002294706,6.989033e-7,0.01162612,0.0004138493,0.0002257439,0.8114156],"study_design_scores_gemma":[0.01673519,0.007798509,0.9375661,0.002831743,0.00009758291,0.00003230938,0.00002534073,0.005404471,0.01528703,0.002477163,0.01150585,0.0002386779],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879229,0.008222186,0.0005680401,0.002196907,0.0001554045,0.0008600769,0.00002273859,0.00001216997,0.00003959595],"genre_scores_gemma":[0.9875072,0.01208014,0.00005520132,0.00003243535,0.0002081781,0.00005464396,0.00004791525,0.00001028587,0.000004056894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.811177,"threshold_uncertainty_score":0.3568801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099955896","doi":"10.1185/030079904125003566","title":"Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval; University of Calgary","funders":"Procter and Gamble","keywords":"Medicine; Tolerability; Osteoporosis; Postmenopausal women; Postmenopausal osteoporosis; Internal medicine; Bone mineral; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.09070662429593646,"gpt":0.4395590446284275,"spread":0.348852420332491,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001953289,0.0001270047,0.0004279307,0.0001171221,0.0001734031,0.00001305451,0.0001045194,0.00007624017,0.00005110826],"category_scores_gemma":[0.001023362,0.00006789861,0.00002987466,0.00027529,0.001110143,0.00004199701,0.00006203611,0.0003209234,0.000001526298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002552637,"about_ca_system_score_gemma":0.001203594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004408609,"about_ca_topic_score_gemma":0.00004503299,"domain_scores_codex":[0.997252,0.0001220294,0.0003667884,0.0003257559,0.001268279,0.0006651837],"domain_scores_gemma":[0.9968708,0.00143458,0.00006553611,0.0002823059,0.0003903923,0.0009564277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0239221,0.007474068,0.02071781,0.003032151,0.0001522622,0.00000818027,0.005730843,0.000002636716,0.0008951741,0.00238772,0.0001780259,0.935499],"study_design_scores_gemma":[0.1001413,0.2390591,0.5728701,0.00414048,0.00009719228,0.00008000823,0.007422687,0.0005167073,0.006896171,0.002715452,0.06563576,0.0004250134],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821678,0.01145157,0.00005019544,0.004277872,0.00008002466,0.001871093,0.00003599217,0.000008465414,0.00005697933],"genre_scores_gemma":[0.978222,0.02111227,0.0001973969,0.0000213042,0.0001312923,0.0002655089,0.0000245385,0.00001221337,0.0000134424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.935074,"threshold_uncertainty_score":0.409037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018780010","doi":"10.1185/030079902125001029","title":"Functional, Cognitive and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; McGill University","funders":"Pfizer","keywords":"Donepezil; Medicine; Alzheimer's disease; Disease; Cognition; Dementia; Psychiatry; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09042586568861398,"gpt":0.4050831020880094,"spread":0.3146572363993954,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004423088,0.0001102157,0.0002013535,0.0002656339,0.000084172,0.00002190779,0.00004227196,0.00005295097,0.0003203612],"category_scores_gemma":[0.0005478993,0.00007812221,0.00002196314,0.0002651258,0.000572962,0.0001067397,0.0001110893,0.0004905524,0.00001021556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001957453,"about_ca_system_score_gemma":0.0001161327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001717962,"about_ca_topic_score_gemma":0.00000285598,"domain_scores_codex":[0.997249,0.0001746319,0.000178842,0.0003067644,0.001709461,0.0003812648],"domain_scores_gemma":[0.9983218,0.0003512187,0.00002477921,0.00008380115,0.0003997349,0.0008186054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002577339,0.002707898,0.747874,0.0003889035,0.00003464508,0.00003480087,0.00008162627,1.993445e-8,0.000003776921,0.00004959996,0.0005685499,0.2456788],"study_design_scores_gemma":[0.009989522,0.002850105,0.9843011,0.001786624,0.00003806039,0.000001635835,0.00004337414,0.000461807,0.0001280185,0.00009252232,0.0002266128,0.00008055991],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98996,0.008447749,0.00006119403,0.0004173567,0.00008051659,0.0009020725,0.00001249151,0.000007636647,0.0001109429],"genre_scores_gemma":[0.9960639,0.003587447,0.000005710349,0.00002526184,0.00006127905,0.0001020096,0.0001128057,0.000009532718,0.00003200544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2455983,"threshold_uncertainty_score":0.350773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2153070704","doi":"10.1185/03007995.2014.918029","title":"Diagnosis, comorbidities, and management of restless legs syndrome","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Restless legs syndrome; Comorbidity; Anxiety; Depression (economics); Disease; Psychiatry; Differential diagnosis; Pediatrics; Physical therapy; Insomnia; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.3307372617754096,"gpt":0.5471310927163142,"spread":0.2163938309409046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004483022,0.0004252077,0.002414863,0.000917103,0.0001616772,0.00007165218,0.0005368402,0.0005309143,0.0003370418],"category_scores_gemma":[0.001108747,0.0003075534,0.00021968,0.0007624354,0.001647797,0.00007121095,0.001225663,0.002449245,0.00007933446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001703498,"about_ca_system_score_gemma":0.0008483987,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005611281,"about_ca_topic_score_gemma":0.000002844117,"domain_scores_codex":[0.9921813,0.0008857236,0.0009829327,0.0008753431,0.004105785,0.000968932],"domain_scores_gemma":[0.9952983,0.001853805,0.0001774869,0.0007828404,0.000269149,0.001618389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002165406,0.000258669,0.0001384737,0.2279164,0.0001601106,0.0002802261,0.00001054242,1.99444e-9,1.487592e-8,0.002296447,0.008098026,0.7608194],"study_design_scores_gemma":[0.0007531722,0.000629765,0.0006654208,0.1766678,0.0001016741,0.0006953327,0.00002049457,0.000009426732,3.282521e-7,0.0001402631,0.8201271,0.0001892574],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002724561,0.9958521,0.00002013939,0.0004950765,0.0004735789,0.002097224,0.00005072246,0.0000280443,0.0007106956],"genre_scores_gemma":[0.000239784,0.9979009,0.00004363261,0.000005339123,0.0002995971,0.0007117139,0.0003967498,0.00006811303,0.0003341679],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8120291,"threshold_uncertainty_score":0.9999377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122016047","doi":"10.1185/030079906x162809","title":"Quetiapine augmentation of treatment-resistant depression: a comparison with lithium","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Louis-H Lafontaine; AstraZeneca (Canada)","funders":"","keywords":"Quetiapine; Lithium (medication); Medicine; Antidepressant; Rating scale; Quetiapine Fumarate; Depression (economics); Internal medicine; Bipolar disorder; Lithium carbonate; Anesthesia; Psychiatry; Antipsychotic; Atypical antipsychotic; Psychology; Schizophrenia (object-oriented programming)","retraction":null,"screen_n_in":null,"score":{"opus":0.1272281207290876,"gpt":0.4826031413226289,"spread":0.3553750205935413,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039528,0.0001552258,0.0003442912,0.0002677386,0.0001202419,0.00001477197,0.0000840164,0.00012121,0.0001667441],"category_scores_gemma":[0.0003802031,0.0000915149,0.00004334188,0.0003078022,0.000381022,0.00007246374,0.00007176476,0.0003548084,0.00001015843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001859335,"about_ca_system_score_gemma":0.0003462775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001305912,"about_ca_topic_score_gemma":0.0000570747,"domain_scores_codex":[0.9970627,0.0001145825,0.0003832546,0.0003513915,0.001669692,0.0004183894],"domain_scores_gemma":[0.9982116,0.0004631318,0.00008864688,0.0002633448,0.0002361677,0.0007371295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.009157358,0.002807023,0.3003228,0.0005964989,0.00009768338,0.00006524561,0.0005133793,3.888091e-7,0.003893771,0.00045217,0.003367558,0.6787261],"study_design_scores_gemma":[0.03001648,0.02547277,0.7290443,0.009222832,0.0001160428,0.000131213,0.0008732872,0.0008558303,0.06181806,0.0003078715,0.1417846,0.0003567834],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730856,0.02073844,0.00185593,0.001417485,0.0002692408,0.001025184,0.000008920597,0.00005751713,0.001541655],"genre_scores_gemma":[0.995551,0.003379116,0.0004094976,0.00001041235,0.0002614388,0.00003567788,0.0001647075,0.00001590348,0.0001722595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6783693,"threshold_uncertainty_score":0.3731869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026692964","doi":"10.1185/030079904x12951","title":"Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Lidocaine; Neuropathic pain; Analgesic; Adverse effect; Osteoarthritis; Anesthesia; Visual analogue scale; Population; Randomized controlled trial; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2304299375111731,"gpt":0.485609507548149,"spread":0.2551795700369758,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02097496,0.0001805195,0.0003875008,0.0002026147,0.0002042427,0.00005717472,0.0001814304,0.00007138983,0.000008855573],"category_scores_gemma":[0.007805462,0.0001076535,0.00002432405,0.0003911462,0.0002394922,0.00009238993,0.0002705097,0.0007357118,0.000001942448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001167121,"about_ca_system_score_gemma":0.0004294964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001815766,"about_ca_topic_score_gemma":0.000207868,"domain_scores_codex":[0.9934036,0.003947539,0.0004319361,0.0004277527,0.001315597,0.0004735471],"domain_scores_gemma":[0.9967384,0.002305824,0.00007105958,0.0002447012,0.0001899058,0.0004500939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01776027,0.03892347,0.01644849,0.0007953696,0.0001831147,0.0009987371,0.01266515,0.000005478664,0.001017437,0.001524909,0.0002589163,0.9094186],"study_design_scores_gemma":[0.2396668,0.5043717,0.1348772,0.05177356,0.0001210955,0.0003143724,0.02515838,0.02665398,0.002307069,0.01319246,0.0004634943,0.001099912],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911518,0.004688303,0.0001660748,0.001922656,0.0001017993,0.001851126,0.00006307958,0.000009407278,0.00004573827],"genre_scores_gemma":[0.9975531,0.002064028,0.00002618006,0.0001045791,0.0001103866,0.00006655236,0.00004533385,0.00001568106,0.00001414028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9083188,"threshold_uncertainty_score":0.934443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147759467","doi":"10.1185/030079906x132541","title":"Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université du Québec à Montréal; Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Epoetin alfa; Kidney disease; Hemoglobin; Anemia; Internal medicine; Erythropoietin; Quality of life (healthcare); Intensive care medicine; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.1609989175567761,"gpt":0.4227268406957679,"spread":0.2617279231389918,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001180975,0.0001182615,0.0002914441,0.0001589655,0.00009262726,0.00001246014,0.00006238913,0.00009126167,0.00006264666],"category_scores_gemma":[0.004367949,0.00008482167,0.00002552694,0.0002684517,0.0004821949,0.00005465468,0.00008601871,0.0005305564,0.000003878483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001442368,"about_ca_system_score_gemma":0.0008216404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004636873,"about_ca_topic_score_gemma":0.00006645895,"domain_scores_codex":[0.9975868,0.0002080157,0.0004122011,0.0003116996,0.001139299,0.0003419756],"domain_scores_gemma":[0.9978135,0.0008149535,0.00007041353,0.0001719946,0.0001293049,0.000999802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002977222,0.0004393913,0.983696,0.001123321,0.000005686476,0.00000288493,0.00003933525,1.016961e-7,0.000004764787,0.0003406246,0.001766194,0.012284],"study_design_scores_gemma":[0.00537314,0.0004274973,0.9902515,0.002147819,0.000007514972,5.885385e-7,0.00002382141,0.00002454472,0.00001481156,0.0003547174,0.001292824,0.00008118273],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896013,0.005680731,0.00004113387,0.004003393,0.00005970203,0.0004441938,0.00006224234,0.00001137023,0.00009592484],"genre_scores_gemma":[0.9978793,0.001095147,0.00006436266,0.00001880519,0.0002252825,0.00002245917,0.000629238,0.00001008922,0.00005530479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01220282,"threshold_uncertainty_score":0.5229158,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150556712","doi":"10.1185/030079906x104786","title":"Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sanofi (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Glimepiride; Pioglitazone; Medicine; Metformin; Type 2 diabetes; Rosiglitazone; Hypoglycemia; Internal medicine; Diabetes mellitus; Randomized controlled trial; Clinical endpoint; Urology; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1340628565789854,"gpt":0.4469974842120171,"spread":0.3129346276330317,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01022143,0.0001764884,0.001197362,0.0004485645,0.00004934541,0.00002461601,0.000108029,0.0001345062,0.00003126698],"category_scores_gemma":[0.005848599,0.0001033876,0.0001403621,0.0004611527,0.0005115644,0.000066663,0.00003802936,0.0004539405,0.000006843212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007432949,"about_ca_system_score_gemma":0.0002660443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001023784,"about_ca_topic_score_gemma":0.00003106735,"domain_scores_codex":[0.9957876,0.001048386,0.0009140378,0.0003673372,0.00145561,0.0004269893],"domain_scores_gemma":[0.9929871,0.006092725,0.0001803639,0.0002313582,0.000270801,0.0002376755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8165779,0.003364052,0.0009082096,0.00005896403,0.0002142732,0.000008634271,0.00003946467,3.621038e-7,0.000009324618,0.002359101,0.0008345419,0.1756252],"study_design_scores_gemma":[0.9650999,0.02571044,0.002294224,0.0006356534,0.00003848541,1.695541e-7,0.00002491083,0.001002535,0.0003258333,0.001048767,0.003723006,0.00009607787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866168,0.005555816,0.00001657348,0.001647129,0.0006834366,0.004034543,0.000003543685,0.00002229435,0.001419843],"genre_scores_gemma":[0.9824262,0.01650951,0.00003978537,0.00003238855,0.0003214722,0.0003122933,0.0002060183,0.00001574441,0.0001365943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1755292,"threshold_uncertainty_score":0.7001742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2104243240","doi":"10.1185/03007995.2012.689956","title":"Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"American Diabetes Association","keywords":"Medicine; Canagliflozin; Sitagliptin; Metformin; Internal medicine; Placebo; Type 2 diabetes; Sitagliptin Phosphate; Urinary system; Creatinine; Gastroenterology; Glycemic; Diabetes mellitus; Renal function; Endocrinology; Urology","retraction":null,"screen_n_in":null,"score":{"opus":0.04561111091520502,"gpt":0.3986547391601533,"spread":0.3530436282449482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002409583,0.0001889669,0.0004534192,0.000558843,0.00004307419,0.00001594976,0.00004847362,0.00008712013,0.00006269911],"category_scores_gemma":[0.0003377413,0.0001241522,0.00002840684,0.0003644024,0.0001623564,0.0001406467,0.00004423863,0.0004942503,0.000004715132],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009425425,"about_ca_system_score_gemma":0.0001021382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001850398,"about_ca_topic_score_gemma":0.0001132329,"domain_scores_codex":[0.9976306,0.0004043636,0.0002884173,0.0002985612,0.0008335837,0.0005444852],"domain_scores_gemma":[0.9988357,0.000436114,0.0000453933,0.0001645803,0.00004764145,0.000470561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005130551,0.0140515,0.9015643,0.0009490024,0.00006101486,0.00006250181,0.0005491905,4.94067e-8,0.0001356632,0.000006777617,0.0001729222,0.07731652],"study_design_scores_gemma":[0.02661171,0.06066542,0.9069517,0.001712883,0.00004811657,0.000003953985,0.00007039731,0.00006462797,0.001698593,0.000006088991,0.002035264,0.0001311997],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952054,0.002407266,6.642062e-7,0.0001140334,0.0002647486,0.001803241,0.000003768084,0.00001439347,0.0001864879],"genre_scores_gemma":[0.996981,0.002529929,0.000001967443,0.0000128432,0.000172963,0.0001702654,0.0000992151,0.00001527291,0.00001649176],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07718533,"threshold_uncertainty_score":0.5062782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1765682497","doi":"10.1185/03007995.2015.1096242","title":"Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Apixaban; Medicine; Dabigatran; Rivaroxaban; Medicare Part D; Vitamin K antagonist; Internal medicine; Warfarin; Pharmacy; Medical prescription; Emergency medicine; Atrial fibrillation; Pharmacology; Family medicine; Prescription drug","retraction":null,"screen_n_in":null,"score":{"opus":0.532264327907032,"gpt":0.5641930501442994,"spread":0.03192872223726739,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005819809,0.0001745421,0.0003131614,0.000108175,0.0002877484,0.00006039454,0.0005216534,0.00008333429,0.0009178118],"category_scores_gemma":[0.007862808,0.0001083051,0.0000532984,0.000702547,0.0006696799,0.00006376738,0.0001333133,0.001080977,0.001344367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009948976,"about_ca_system_score_gemma":0.002222143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001169593,"about_ca_topic_score_gemma":0.00001119158,"domain_scores_codex":[0.9941924,0.0004634738,0.0004378168,0.0005108271,0.003835503,0.0005599693],"domain_scores_gemma":[0.9954955,0.0008210356,0.00007933076,0.0006399071,0.0007343109,0.002229922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009266387,0.00149548,0.02601733,0.0003722363,0.00004345003,0.0000237341,0.0004386662,0.000001408845,0.0004082777,0.004693691,0.6140273,0.3515518],"study_design_scores_gemma":[0.007330754,0.002678842,0.05701828,0.005528414,0.00002527061,0.00003049204,0.0009871969,0.02616558,0.001251195,0.001105148,0.8974138,0.0004650218],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2661319,0.009541685,0.04391005,0.6456295,0.005324312,0.007420174,0.0001148635,0.0003063242,0.02162124],"genre_scores_gemma":[0.9931045,0.002068519,0.0002202567,0.002999703,0.0006106537,0.0003663066,0.00009904652,0.0000157104,0.0005153589],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7269725,"threshold_uncertainty_score":0.9999955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155011514","doi":"10.1185/030079905x43712","title":"Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Nicotine withdrawal; Craving; Irritability; Clinical psychology; Confirmatory factor analysis; Varenicline; Exploratory factor analysis; Mood; Anxiety; Psychiatry; Anger; Construct validity; Anhedonia; Medicine; Psychology; Smoking cessation; Psychometrics; Nicotine; Addiction; Structural equation modeling; Schizophrenia (object-oriented programming)","retraction":null,"screen_n_in":null,"score":{"opus":0.0761572998217576,"gpt":0.4341971350825373,"spread":0.3580398352607797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00173753,0.00007316912,0.0001307382,0.00005252377,0.0002268433,0.00001048579,0.0001517469,0.000113863,0.0002123809],"category_scores_gemma":[0.0017614,0.0000353089,0.00005079691,0.0002944202,0.0005508786,0.00003940346,0.0001556846,0.0009875374,0.00000427049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003667683,"about_ca_system_score_gemma":0.0002157785,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003239134,"about_ca_topic_score_gemma":0.000005974269,"domain_scores_codex":[0.9973201,0.0001584712,0.0002273953,0.0001839273,0.001856612,0.0002534999],"domain_scores_gemma":[0.9987162,0.0005303037,0.00004397029,0.0002826293,0.0002112834,0.0002155782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00033009,0.0009646874,0.4517219,0.0002739125,0.00003096004,0.000001504927,0.001178,0.000002853844,0.001142795,0.005057735,0.01663297,0.5226626],"study_design_scores_gemma":[0.00228802,0.0004532728,0.8186908,0.004940855,0.00004032181,0.00006561908,0.0004271098,0.0022127,0.008128788,0.0007725289,0.1618322,0.0001478061],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9775743,0.002323389,0.000213197,0.01887479,0.0005973965,0.000298033,0.000004104109,0.00001042815,0.0001043981],"genre_scores_gemma":[0.9972953,0.001492493,0.0001171284,0.00009495225,0.0008849523,0.00001611543,0.00001787125,0.000007484749,0.00007368213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5225148,"threshold_uncertainty_score":0.4290414,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058758881","doi":"10.1185/03007990802484234","title":"The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Respiratory viral infections research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Children's Hospital of Eastern Ontario; University of Manitoba; St. Joseph’s Healthcare Hamilton; McMaster University; McMaster Children's Hospital; Toronto Rehabilitation Institute; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Abbott Laboratories","keywords":"Palivizumab; Medicine; Gestational age; Respiratory system; Pediatrics; Bronchopulmonary dysplasia; Pregnancy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1422554641747951,"gpt":0.4593264288112451,"spread":0.31707096463645,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003552279,0.0001332237,0.0004435766,0.001180952,0.0002707334,0.00001761885,0.000195305,0.0001832406,0.00004351727],"category_scores_gemma":[0.005577757,0.000083224,0.00009413008,0.002032298,0.001347365,0.00006871919,0.00004632521,0.0008621802,0.000001331235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002837138,"about_ca_system_score_gemma":0.005224009,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005652421,"about_ca_topic_score_gemma":0.02076771,"domain_scores_codex":[0.996107,0.0008855842,0.0004274894,0.0003383182,0.001717622,0.0005239176],"domain_scores_gemma":[0.9952126,0.002873237,0.00007683115,0.0003218408,0.0009137871,0.0006017452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03171277,0.003307744,0.695791,0.007901341,0.001200586,0.0003365286,0.0007217893,0.0002534183,0.006322318,0.002469006,0.001967576,0.248016],"study_design_scores_gemma":[0.007372174,0.007315656,0.952015,0.002325219,0.00004621616,0.00001227048,0.00007242795,0.003146461,0.004006832,0.0001875607,0.02331596,0.0001841663],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991864,0.003532779,0.0009207401,0.0002493206,0.00009528328,0.003049968,0.000156616,0.000008936715,0.000122404],"genre_scores_gemma":[0.998424,0.0006312483,0.00003052065,0.00001655937,0.0000829116,0.0006625492,0.0001295838,0.00001386563,0.000008768039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2562241,"threshold_uncertainty_score":0.9971007,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131442583","doi":"10.1185/03007990802381364","title":"Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Diclofenac; Intensive care medicine; Pharmacology; Traditional medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2750873171027512,"gpt":0.5253570267360547,"spread":0.2502697096333034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002528635,0.0002598451,0.001568245,0.00009130448,0.0001587751,0.000006571327,0.0003459707,0.0003716855,0.00002432671],"category_scores_gemma":[0.01540096,0.0001066358,0.0004665034,0.0004207576,0.001686791,0.00003647552,0.0005834888,0.002076814,0.000003642215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004998214,"about_ca_system_score_gemma":0.001310629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004572444,"about_ca_topic_score_gemma":7.507983e-7,"domain_scores_codex":[0.9946367,0.001609556,0.001166156,0.0003653905,0.001828453,0.0003937095],"domain_scores_gemma":[0.9960354,0.002337226,0.0002717803,0.0005142192,0.0002946714,0.0005467358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002934575,0.0001770784,0.0007174304,0.2901732,0.00005442113,0.00000364491,0.00001512986,3.248929e-10,6.441365e-7,0.0001528007,0.005007421,0.7036689],"study_design_scores_gemma":[0.0006504752,0.0003091793,0.001077948,0.3109006,0.0001504621,0.00007486246,0.000001158718,0.00002295507,0.00002459699,0.00001326755,0.6867015,0.00007296769],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001105262,0.9937018,0.000004104696,0.0008448879,0.001475896,0.00280783,0.000005884725,0.000007680414,0.00004664727],"genre_scores_gemma":[0.0004863309,0.998271,0.000003953791,0.0001406329,0.0009375925,0.00008890205,0.0000165403,0.00002012914,0.00003486817],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7035959,"threshold_uncertainty_score":0.9928927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2062448901","doi":"10.1185/03007995.2014.944973","title":"Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Nilotinib; Imatinib; Internal medicine; Adverse effect; Incidence (geometry); Imatinib mesylate; Quality of life (healthcare); Chronic myelogenous leukemia; Philadelphia chromosome; Bosutinib; Tyrosine-kinase inhibitor; Myeloid leukemia; Gastroenterology; Leukemia; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.09152452362728754,"gpt":0.4554350368855942,"spread":0.3639105132583066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003054628,0.0003648636,0.001321172,0.0006497792,0.0001038297,0.000005425657,0.0002844424,0.0003169626,0.0001738233],"category_scores_gemma":[0.01392786,0.0002759545,0.0002170259,0.0008341206,0.00040634,0.0001283114,0.0001505877,0.001158139,0.000009615326],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01060748,"about_ca_system_score_gemma":0.01212546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00329846,"about_ca_topic_score_gemma":0.0009647705,"domain_scores_codex":[0.9933997,0.001022089,0.001875379,0.0007241227,0.001830825,0.001147875],"domain_scores_gemma":[0.9945451,0.002912696,0.0005704781,0.0004747855,0.000418944,0.001077997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03567862,0.02287272,0.2401271,0.02124262,0.0006992878,0.0000505702,0.004743189,0.0003681284,0.001914419,0.0003667719,0.0023319,0.6696047],"study_design_scores_gemma":[0.1462065,0.03814866,0.7739416,0.02198563,0.00001887158,0.000006909671,0.0001087202,0.01854683,0.0003885219,0.0002067662,0.00007874313,0.000362241],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933808,0.002017257,0.00004479814,0.0006875753,0.0002869749,0.003305965,0.0002362914,0.00002082199,0.00001951289],"genre_scores_gemma":[0.9920892,0.006213161,0.00003493941,0.00003443248,0.0002459089,0.0002322914,0.001100535,0.00004343415,0.000006117594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6692425,"threshold_uncertainty_score":0.9999692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041031356","doi":"10.1185/030079906x112561","title":"Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Université Laval; Hôpital Louis-H Lafontaine; AstraZeneca (Canada); Université de Montréal","funders":"","keywords":"Quetiapine; Medicine; Psychiatry; Schizophrenia (object-oriented programming); Extrapyramidal symptoms; Craving; Substance abuse; Clozapine; Cannabis; Psychosis; Addiction; Antipsychotic","retraction":null,"screen_n_in":null,"score":{"opus":0.1049908936912379,"gpt":0.4098819037209551,"spread":0.3048910100297172,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001118185,0.0002098153,0.000383903,0.0003315723,0.0001999062,0.0002067661,0.0002411221,0.0001186244,0.00007932657],"category_scores_gemma":[0.0005956481,0.0001427899,0.00001510901,0.000527866,0.0006018278,0.0004067217,0.0002223228,0.0009081525,0.000009019863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001123625,"about_ca_system_score_gemma":0.0005139271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001251513,"about_ca_topic_score_gemma":0.006637502,"domain_scores_codex":[0.9960553,0.0003090214,0.0003546525,0.0006372877,0.001893139,0.0007505891],"domain_scores_gemma":[0.9980938,0.0003439677,0.0000461137,0.0003600551,0.0001516587,0.001004425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3925718,0.01285307,0.3939872,0.0001698028,0.00004111557,0.00005979928,0.00005930231,1.141593e-7,0.000004044226,0.008915118,0.001705753,0.1896329],"study_design_scores_gemma":[0.2741035,0.01398612,0.7029675,0.000874958,0.000007776051,0.000006118648,0.00001775815,0.0002892046,0.00001501338,0.004560536,0.002975776,0.0001957851],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911479,0.003392003,0.00002995197,0.003054378,0.0001373941,0.002128402,0.00002158659,0.000025533,0.0000629007],"genre_scores_gemma":[0.9939964,0.004536846,0.0003536648,0.00001861391,0.0003115142,0.0001825266,0.0005269203,0.00002660323,0.00004691608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3089802,"threshold_uncertainty_score":0.5822803,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109156797","doi":"10.1185/030079903125002469","title":"A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Etoricoxib; Medicine; Tolerability; Diclofenac; Osteoarthritis; WOMAC; Clinical endpoint; Anesthesia; Clinical trial; Physical therapy; Adverse effect; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05962323090727992,"gpt":0.4094679379635202,"spread":0.3498447070562403,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001144333,0.00007781368,0.0003011969,0.00007456051,0.00005268594,0.000005008449,0.00004752762,0.00007307267,0.00001727345],"category_scores_gemma":[0.00134261,0.00004341726,0.00001457218,0.0002121144,0.0006433284,0.00002841305,0.00005338067,0.0004292235,2.382115e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001888733,"about_ca_system_score_gemma":0.0001528322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001259993,"about_ca_topic_score_gemma":0.00001045273,"domain_scores_codex":[0.9982009,0.0003165897,0.0002539735,0.0001741684,0.0008456645,0.0002087083],"domain_scores_gemma":[0.9989389,0.0004950698,0.00005021696,0.0001494306,0.0001245959,0.0002417702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003772161,0.0004584458,0.8608312,0.000475754,0.000005650505,4.860955e-7,0.0003976878,3.138712e-8,0.00003479405,0.000312044,0.00003663305,0.1370701],"study_design_scores_gemma":[0.00550181,0.002130507,0.9884214,0.00117508,0.000005558414,0.00000171789,0.00007274844,0.00005029505,0.0006318024,0.0001019999,0.001862085,0.00004494902],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912912,0.007732416,0.000006132411,0.0001530323,0.0001574211,0.0006041033,0.000002596426,0.000002578304,0.00005047529],"genre_scores_gemma":[0.999231,0.0007037072,0.000006388263,0.00000733999,0.00002858908,0.00001223412,0.000003825495,0.000004932517,0.000001990978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1370251,"threshold_uncertainty_score":0.237037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137919051","doi":"10.1185/030079906x89685","title":"Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Donepezil; Tolerability; Rivastigmine; Internal medicine; Butyrylcholinesterase; Acetylcholinesterase; Population; Adverse effect; Cholinesterase; Oncology; Dementia; Disease; Aché","retraction":null,"screen_n_in":null,"score":{"opus":0.04012341822008597,"gpt":0.4254921382347489,"spread":0.3853687200146629,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002926224,0.0001417603,0.0002828978,0.0005485663,0.00006327449,0.00001956699,0.000119822,0.00005392976,0.0002557306],"category_scores_gemma":[0.003423754,0.00008092119,0.00003392204,0.0006238574,0.0003365055,0.00004557505,0.0001403711,0.0004886484,0.00002954688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005284272,"about_ca_system_score_gemma":0.0003423148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004099357,"about_ca_topic_score_gemma":0.00001049831,"domain_scores_codex":[0.9954952,0.000689967,0.0002534034,0.0003613563,0.0026688,0.0005312772],"domain_scores_gemma":[0.9972363,0.001315777,0.00002486035,0.0002107297,0.0002181118,0.0009942132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1691595,0.002266807,0.6034212,0.000421298,0.0000249513,0.0002015012,0.00002703725,3.149312e-7,0.00004387574,0.00005306112,0.003285421,0.2210951],"study_design_scores_gemma":[0.01020496,0.02189521,0.9582492,0.002159626,0.00001471794,9.582088e-7,0.000006733477,0.00003297452,0.0006221742,0.00002868134,0.006700482,0.00008430139],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963245,0.0005850039,0.00002242543,0.001280222,0.00008099117,0.001417314,0.00001908913,0.00001112281,0.0002593398],"genre_scores_gemma":[0.9992946,0.0001541028,0.0000105982,0.00003323003,0.0001199641,0.0001326741,0.0001328756,0.00001369772,0.0001083014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3548281,"threshold_uncertainty_score":0.40988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117216433","doi":"10.1185/030079905x59102","title":"Statins and LDL‐cholesterol lowering: an overview","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"European Society of Cardiology; University of Waterloo; Merck KGaA","keywords":"Medicine; Ldl cholesterol; Cholesterol; Cholesterol lowering; Ezetimibe; Pharmacology; Atorvastatin; Statin; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.4106502170329484,"gpt":0.5698913529223524,"spread":0.159241135889404,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00409766,0.0003298334,0.001543142,0.0003040018,0.0001809527,0.00008682888,0.0002019436,0.0004161507,0.0002723615],"category_scores_gemma":[0.0009027829,0.0002235218,0.0002445062,0.000330628,0.0003629225,0.0001066735,0.0003133069,0.002200518,0.0000533089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001311179,"about_ca_system_score_gemma":0.001495424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006040617,"about_ca_topic_score_gemma":0.00001650524,"domain_scores_codex":[0.9948393,0.0005520947,0.000590163,0.000732124,0.002565287,0.0007210521],"domain_scores_gemma":[0.9966877,0.0002291573,0.00008185736,0.0005981755,0.0001652088,0.002237909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000138406,0.0001956533,0.000008617588,0.04120529,0.00006331667,0.00002050372,0.00003545636,1.373148e-9,2.04508e-8,0.0001886373,0.0007237546,0.9575449],"study_design_scores_gemma":[0.0007913074,0.0007485764,0.0001285537,0.04865942,0.00008254467,0.0002609536,0.0000153586,0.00001456123,1.168186e-7,0.00003490875,0.9490904,0.000173317],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007416317,0.9973798,0.00004968795,0.0003745862,0.0004178887,0.001501416,0.00003085013,0.0000259149,0.0001457299],"genre_scores_gemma":[0.00002078489,0.9964833,0.0000363932,0.00004874615,0.002754803,0.0001700076,0.0003742765,0.00004718186,0.00006451053],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9573716,"threshold_uncertainty_score":0.9560276,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011186711","doi":"10.1185/030079905x75069","title":"Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Etoricoxib; Tolerability; Diclofenac; Low back pain; Discontinuation; Randomized controlled trial; Clinical endpoint; Visual analogue scale; Physical therapy; Analgesic; Anesthesia; Adverse effect; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05000715325874751,"gpt":0.3805794551941674,"spread":0.3305723019354199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02117611,0.0001766454,0.0007700311,0.0003289179,0.00004473863,0.000008240128,0.00009102998,0.0001496062,0.00002805467],"category_scores_gemma":[0.01002441,0.0001210596,0.00004446254,0.0004965712,0.001153776,0.0001189566,0.0001070764,0.0006096651,6.716307e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001697617,"about_ca_system_score_gemma":0.0003336043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001831416,"about_ca_topic_score_gemma":0.000136294,"domain_scores_codex":[0.9943563,0.002283035,0.0009540559,0.0004487802,0.001597591,0.0003602462],"domain_scores_gemma":[0.9952016,0.003656579,0.0002089028,0.000243229,0.0003228826,0.0003667974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3101569,0.01015477,0.4152344,0.003786178,0.00007333899,0.000004613435,0.003690167,0.000008886595,0.0000817223,0.00005213821,0.0003014533,0.2564555],"study_design_scores_gemma":[0.4756683,0.004572874,0.5117105,0.003367737,0.00001492626,9.69481e-7,0.00023093,0.003816483,0.0002163166,0.00002249409,0.0002546366,0.0001238113],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938849,0.001930923,0.00003207902,0.0004684527,0.0001471435,0.003504978,0.00001180976,0.000004926842,0.00001481103],"genre_scores_gemma":[0.9982946,0.001220816,0.00002376197,0.00000321056,0.0002416653,0.0001033033,0.00009442578,0.00001159939,0.000006614367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2563316,"threshold_uncertainty_score":0.9983146,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006625121","doi":"10.1080/03007995.2020.1729708","title":"Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Varenicline; Medicine; Smoking cessation; Nicotine replacement therapy; Adverse effect; Clinical trial; Pharmacology; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.6961278574739443,"gpt":0.6769596484335964,"spread":0.01916820904034799,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001348759,0.0002008516,0.00112388,0.000198079,0.0001572638,0.00002343509,0.0001498584,0.0004448773,0.00007565924],"category_scores_gemma":[0.006177403,0.0001476622,0.0002164575,0.0004103828,0.0004255188,0.00005272938,0.0001691787,0.001126424,0.000001724842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007736923,"about_ca_system_score_gemma":0.0007791676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001669692,"about_ca_topic_score_gemma":0.000001612773,"domain_scores_codex":[0.9965658,0.0003232002,0.001083688,0.0005420496,0.00118311,0.0003022132],"domain_scores_gemma":[0.9970878,0.001351395,0.0002046689,0.0002622539,0.0003327256,0.0007611394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002041413,0.0003156331,0.001294352,0.006319461,0.00003039692,0.000001630906,0.00009440359,3.727015e-8,1.849954e-7,0.0004250409,0.001469682,0.989845],"study_design_scores_gemma":[0.001538966,0.0006246101,0.004050638,0.0136811,0.0001742096,0.0000160406,0.00005199143,0.0004304317,0.000001249488,0.00007287922,0.979225,0.0001329063],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00155067,0.9931962,0.001593962,0.0004511902,0.001254685,0.001802742,0.000103654,0.00003388468,0.00001298256],"genre_scores_gemma":[0.003605247,0.9940851,0.00005561164,0.00001053178,0.0006940428,0.0001123629,0.001401144,0.00002409015,0.0000118955],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9897121,"threshold_uncertainty_score":0.7395375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987970762","doi":"10.1185/03007995.2010.515900","title":"Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Institute of Mental Health; Institut National de la Santé et de la Recherche Médicale; Eli Lilly and Company","keywords":"Discontinuation; Medicine; Concordance; Antipsychotic; Adverse effect; Schizophrenia (object-oriented programming); Clinical endpoint; Continuation; Psychiatry; Clinical trial; Antipsychotic drug; Pediatrics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08885910751449391,"gpt":0.4495784966865421,"spread":0.3607193891720482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000848536,0.00009267507,0.000252924,0.0001611484,0.00007072953,0.00001897735,0.00005278134,0.00008358036,0.00001401581],"category_scores_gemma":[0.001723915,0.00005409404,0.00003862295,0.0001443824,0.0005473364,0.00004650901,0.00002451422,0.0002654789,3.422594e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001940449,"about_ca_system_score_gemma":0.0001884883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001326447,"about_ca_topic_score_gemma":0.0005030124,"domain_scores_codex":[0.9984447,0.0001516148,0.0002788391,0.0002555644,0.000663813,0.0002054188],"domain_scores_gemma":[0.9978933,0.001424749,0.0000663937,0.0001730335,0.0002153645,0.0002271984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.008110846,0.002369462,0.06794491,0.00007949859,0.0000488804,0.000002698189,0.004006839,1.140253e-8,0.0004096796,0.005841644,0.0001129752,0.9110726],"study_design_scores_gemma":[0.01389174,0.009024787,0.961244,0.0006240394,0.00003511673,0.000007592945,0.003935573,0.001102311,0.0009243289,0.006513688,0.002610826,0.0000859859],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869568,0.008687371,0.00005350574,0.002997913,0.0001239308,0.001094976,0.00006379042,0.000003276259,0.00001845361],"genre_scores_gemma":[0.9784769,0.02053585,0.0006059032,0.000003681299,0.0001751671,0.00008840153,0.0001056158,0.000005720872,0.000002770968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9109865,"threshold_uncertainty_score":0.2205891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129869980","doi":"10.1185/030079904x2754","title":"Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Analgesic; WOMAC; Tramadol; Lidocaine; Adverse effect; Anesthesia; Hyperalgesia; Duloxetine; Brief Pain Inventory; Physical therapy; Chronic pain; Internal medicine; Nociception","retraction":null,"screen_n_in":null,"score":{"opus":0.1506651205344753,"gpt":0.4425841042584931,"spread":0.2919189837240178,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826678,0.0001540773,0.0003011058,0.0002362152,0.0001335435,0.00003226415,0.0001120866,0.0001909403,0.0002026652],"category_scores_gemma":[0.002143238,0.0001220336,0.00005269948,0.0003327685,0.0001505627,0.0000686124,0.0001347768,0.0008708971,0.00002837424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001793979,"about_ca_system_score_gemma":0.000434405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002270017,"about_ca_topic_score_gemma":0.00008690322,"domain_scores_codex":[0.9970577,0.0002028106,0.0003018648,0.0004201014,0.00135689,0.0006606735],"domain_scores_gemma":[0.9985343,0.0003435684,0.00002468656,0.0001950986,0.00009574106,0.0008066632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0004112316,0.003113238,0.008379784,0.0006379029,0.00004177053,0.0009269947,0.0006021542,7.078883e-7,0.000942083,0.1037071,0.0004346059,0.8808025],"study_design_scores_gemma":[0.1167953,0.03285855,0.0560071,0.02984585,0.00004842363,0.001117588,0.002981865,0.008926431,0.006383095,0.5893968,0.1538889,0.00175005],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7663135,0.01778873,0.1572245,0.05202984,0.002117078,0.003223184,0.00004367549,0.0001833966,0.001076119],"genre_scores_gemma":[0.994061,0.003358542,0.001742311,0.0002402424,0.0002992195,0.0001079209,0.0001116217,0.00001802515,0.00006110657],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8790524,"threshold_uncertainty_score":0.4976387,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}